493 results found

Given the potential risks posed to public health, the pharmaceutical sector is one of the most strictly regulated sectors in many countries, including Turkey.

Following the enforcement of the new Communiqué on Pricing of Human Medicinal Products last September, the Ministry of Health ("Ministry") rolled up its sleeves for a new regulation concerning human medicinal products: The Regulation on Manufacturing Plants of Human Medicinal Products ("Regulation").

Turkey's pharmaceutical pricing system undergoes a major restructuring with the publication of the New Pricing Communiqué on August 29, 2026, implementing significant changes including increased Euro/TRY conversion rates, incentive mechanisms for first generic market entry, and the introduction of value-based pricing concepts. The new regulations establish detailed provisions for special product categories while leaving certain implementation details to future secondary legislation.

Turkey has adopted a new regulation modifying and clarifying rules on promoting medicines for human use and beyond. With limited exception, the new regulation entered into force on July 3, 2015.

In recent years, rare diseases have garnered increasing attention in the pharmaceutical sector, primarily due to their growing prevalence and the lack of standard diagnostic and therapeutic solutions.

The Regulation on the Sales, Advertisement and Promotion of Medical Devices has come into force.

The Regulation Amending the Regulation on Manufacturing Facilities for Medicinal Products for Human Use (“Amending Regulation”), published in the Official Gazette dated 21.10.2026 and numbered 33407, introduces amendments to the Regulation on Manufacturing Facilities for Medicinal Products for Human Use (“Regulation”).

Turkey has become one of the world's most popular destinations for cosmetic surgery, with thousands of patients travelling each year for procedures such as rhinoplasty, breast augmentation, liposuction, BBL, dental veneers...

Ortak Pazarlanan Beşerî Tıbbi Ürünlere İlişkin Kılavuz ("Kılavuz"), ortak pazarlanan (co-marketing) ürünlerin ruhsat başvurularının ve ruhsatlı ortak pazarlanan ürünlerin...

20 Nisan 2023 tarihinde yayımlanan düzenlemelerle, gıda ve takviye edici gıdalarda sağlık beyanı kullanımına dair mevzuatta önemli değişiklikler yapılmıştır.

The agricultural sector is not merely an area of economic activity, but also a security component that directly affects the quality of life.

Bureaucratic burden and uncertainties caused by lack of sufficient and relevant regulation were blamed by the pharmaceutical industry as one of the significant reasons for the relatively low number of clinical trials conducted in Turkey despite its potential in terms of population, qualified personnel and geographical location.

On April 12, 2021, the European Commission announced to have approved an important package for

Following significant regulatory changes in 2023 regarding health claims for food and dietary supplements in Turkey, the regulatory landscape has shifted toward consolidation and implementation rather than new legislative interventions.

İnsani Amaçlı İlaca Erken Erişim Programı ("Program") Türkiye'de Türkiye İlaç ve Tıbbi Cihaz Kurumu ("Kurum")

Turkish Competition Authority ("TCA") has published its 2022 Annual Report ("Report") where it presents an overview of its activities in the past year.

The Turkish Competition Authority has imposed a significant administrative fine on AVIXA for exclusionary and exploitative practices in the dual-active ingredient nasal spray market.

Turkey has introduced comprehensive new regulations governing aromatherapeutic products and medicinal herbal teas, establishing standalone licensing regimes that separate these products from food supplements and general food legislation. The regulatory package also brings significant amendments to existing frameworks for traditional herbal medicinal products, foods for special medical purposes, and medical device sales, introducing new obligations for manufacturers, distributors, and sales channels across p